[Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].
To evaluate the efficacy of the enterokinetic prucalopride (resolor) in patients with chronic constipation. The effect of treatment with prucalopride (resolor) in 109 patients with chronic constipation was analyzed. The effect was noted in 82% of the patients; 61 patients were fully satisfied with treatment results. Among the adverse reactions, headache that was particularly significant on the first days of use, diarrhea, and cramping abdominal pain were reported by 35, 17, and 13% of the included patients, respectively. The authors' experience with prucalopride demonstrated that the patients with chronic constipation displayed the good efficacy of the drug in both the frequency of stool and the elimination of all other constipation symptoms (straining effort, incomplete bowel emptying sensation, solid stool, bloating), and its good tolerability. Prucalopride (resolor) exerts a predictable effect, can extend a physician's capacity to arrest chronic constipation, and, when the drug is used, requires no long-term dose adjustment.